UPDATE : Monday, September 7, 2020
상단여백
Seoul accepts Bayer’s request to reduce study subjects of cancer drug
The government has accepted Bayer’s request to reduce the number of review ...
by Lee Hye-seon  |  2019-02-07 16:06
라인
FDA starts inspecting SK Biopharm’s epilepsy treatment
SK Biopharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Lee Han-soo  |  2019-02-07 16:01
라인
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment
Mediforum has signed a contract research agency contract with LSK Global PS...
by Lee Han-soo  |  2019-02-07 14:40
라인
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales
MSD’s cancer immunotherapy Keytruda (ingredient: pembrolizumab) beat Bristo...
by Kim Yun-mi  |  2019-02-07 14:40
라인
FDA OKs Daewoong’s BTX
Daewoong Pharmaceutical said that it received approval from the U.S. Food a...
by Lee Han-soo  |  2019-02-07 11:09
라인
Pfizer feeling bittersweet over Korea’s biosimilars
Pfizer has lately seen both positive and negative impacts of Korean biosimi...
by Lee Han-soo  |  2019-02-01 17:04
라인
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease
Novartis Korea’s dementia treatment Exelon (rivastigmine) obtained expanded...
by Kim Yun-mi  |  2019-02-01 17:02
라인
‘Alunbrig works better for ALK-positive non-small cell lung cancer’
Second-line treatment options are increasing for patients with anaplastic l...
by Kim Yun-mi  |  2019-02-01 15:38
라인
Medytox, Daewoong continue to squabble over BTX
A heated debate is continuing between Medytox and Daewoong Pharmaceuticals ...
by Lee Han-soo  |  2019-02-01 15:36
라인
Santen Pharma to sell Huonland’s eye drop in China
Huonland said Wednesday that it has signed a memorandum of understanding wi...
by Lee Han-soo  |  2019-02-01 11:56
라인
14 pharmaceuticals to release gastritis generic drugs soon
Fourteen pharmaceutical firms are to roll out generic copies of Stillen 2X ...
by Lee Hye-seon  |  2019-02-01 11:55
라인
AbClon transfers target antibody technology to GC Labcell
GC Labcell said Wednesday that it has signed a 3 billion won ($2.7 million)...
by Lee Han-soo  |  2019-01-31 16:23
라인
Novo Nordisk’s growth hormone injection gets expanded coverage
Novo Nordisk said Wednesday that the Ministry of Health and Welfare would e...
by Lee Han-soo  |  2019-01-31 15:18
라인
‘Pseudoephedrine-containing drugs could cause acute skin reaction’ 
The government is likely to add a warning in the instructions of pseudoephe...
by Lee Hye-seon  |  2019-01-31 14:34
라인
Kwangdong dismisses rumors of terminating sales for Contrav
Kwangdong Pharmaceutical denied Thursday rumors of the company stopping sal...
by Lee Han-soo  |  2019-01-31 14:32
라인
Ipsen’s renal cancer drug Carbometyx gets insurance benefit
Ipsen Korea’s advanced renal cell carcinoma treatment Carbometyx (cabozanti...
by Park Gi-taek  |  2019-01-31 11:13
라인
₩4.7 billion spent on compensation for side effect injuries in 4 years
Korea used 4.74 billion won ($4.24 million) to compensate the damages such ...
by Lee Hye-seon  |  2019-01-30 17:18
라인
Pfizer’s lung cancer drug Xalkori threatened by new rivals
Pfizer’s Xalkori (ingredient: crizotinib) has been solidifying its status a...
by Kim Yun-mi  |  2019-01-30 12:34
라인
Biogen, NHIS begin price talk for spinal muscular atrophy treatment
The National Health Insurance Service (NHIS) and Biogen started price negot...
by Lee Han-soo  |  2019-01-30 11:43
라인
GC to stop making 1st thrombolytic agent amid poor sales
GC will stop manufacturing Urokinase, Korea’s first thrombolytic agent, aft...
by Lee Han-soo  |  2019-01-29 16:44
여백
여백
여백
Back to Top